HIV vaccine design and the neutralizing antibody problem (Q46474020)

22 December 2017

title

HIV vaccine design and the neutralizing antibody problem (English)

1 reference

22 December 2017

1 reference

1 reference

1 reference

0 references

9

Ian A Wilson

1 reference

22 December 2017

8

Joseph Sodroski

1 reference

22 December 2017

7

Gary J Nabel

1 reference

22 December 2017

Peter D. Kwong

5

object named as

Peter D Kwong

1 reference

22 December 2017

Dennis R. Burton

1

object named as

Dennis R Burton

1 reference

22 December 2017

Richard T. Wyatt

10

object named as

Richard T Wyatt

1 reference

22 December 2017

author name string

Ronald C Desrosiers

2

1 reference

22 December 2017

Robert W Doms

3

1 reference

22 December 2017

Wayne C Koff

4

1 reference

22 December 2017

John P Moore

6

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

22 December 2017

published in

Nature Immunology

1 reference

22 December 2017

volume

5

1 reference

22 December 2017

page(s)

233-236

1 reference

22 December 2017

issue

3

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1038/ni0304-233

exact match

0 references

cites work

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

1 reference

https://api.crossref.org/works/10.1038%2FNI0304-233

The antiviral activity of antibodies in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0304-233

Viral persistence: HIV's strategies of immune system evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0304-233

Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0304-233

Antibody domain exchange is an immunological solution to carbohydrate cluster recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0304-233

Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0304-233

Alternative conformations of HIV-1 V3 loops mimic beta hairpins in chemokines, suggesting a mechanism for coreceptor selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0304-233

The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0304-233

Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0304-233

Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0304-233

Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0304-233

Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0304-233

Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0304-233

Solid-phase proteoliposomes containing human immunodeficiency virus envelope glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0304-233

Purification, Characterization, and Immunogenicity of a Soluble Trimeric Envelope Protein Containing a Partial Deletion of the V2 Loop Derived from SF162, an R5-Tropic Human Immunodeficiency Virus Type 1 Isolate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0304-233

Hyperglycosylated Mutants of Human Immunodeficiency Virus (HIV) Type 1 Monomeric gp120 as Novel Antigens for HIV Vaccine Design

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0304-233

Crosslinked HIV-1 envelope-CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0304-233

Medicine. The need for a global HIV vaccine enterprise

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0304-233

Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0304-233

21 January 2018

Identifiers

DOI

10.1038/NI0304-233

1 reference

22 December 2017

Dimensions Publication ID

1038607265

0 references

Fatcat ID

release_gmlrwmksurg5xjg5prh2frmbse

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gmlrwmksurg5xjg5prh2frmbse

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

14985706

1 reference

22 December 2017